UNSPSC 51172126: Drotaverine or drotaverine hydrochloride

This classification denotes an antispasmotic agent with the molecular formulas C24H31NO4 and C24H31NO4.ClH, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers 98QS4N58TW and 24ZVH4C669. European Medicines Agency schedules Drotaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB06415MIG and SUB01843MIG.

UNSPSC 51172126 Drotaverine or drotaverine hydrochloride is a Commodity code covering a specific pharmaceutical product used in state and local government procurement, primarily through pharmacy benefit programs, correctional health services, and multistate cooperative purchasing vehicles. The code sees application in correctional drug testing and offender health management, where drotaverine may be stocked as part of institutional pharmaceutical inventories, and in state health and human services pharmacy benefit programs that source generic and branded pharmaceuticals for employee health plans and state agency populations. State and local buyers under this code include correctional departments (community supervision and corrections agencies), state health and human services commissions managing pharmacy benefits, and multistate purchasing cooperatives that aggregate demand across participating state and local jurisdictions.

Recent activity centers on Texas and Minnesota. The Collin County Community Supervision and Corrections Department issued RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing services, which implies institutional pharmaceutical stocking for correction and health management purposes under a $600,000 estimated contract value through September 2026. The Texas Health and Human Services Commission issued RFI No. HHS0017013 (response deadline April 3, 2026) exploring direct-to-manufacturer prescription programs and pharmacy benefit capabilities across state employee and agency populations. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with awarded vendors effective July 1, 2026. The code shows modest recent activity concentrated in state pharmacy benefit and correctional health procurement; opportunities are sparse and tend toward broad pharmaceutical category solicitations rather than single-ingredient procurement.